PMID- 16892139 OWN - NLM STAT- MEDLINE DCOM- 20080527 LR - 20171116 IS - 1671-167X (Print) IS - 1671-167X (Linking) VI - 38 IP - 4 DP - 2006 Aug 18 TI - [Induction of skin allograft tolerance in mice by using anti-alphabeta T cell receptor and anti-CD80 monoclonal antibodies combined with bone marrow transfusion]. PG - 365-9 AB - OBJECTIVE: To explore the role of anti-alphabeta T cell receptor (TCR) and anti-CD80 monoclonal antibodies (mAbs) combined with donor bone marrow cells (BMCs) infusion in the induction of murine skin allografts tolerance. METHODS: On day 0, 2 x 10(8) BMCs of BALB/c mice were injected into recipient C57BL/6 mice via the tail vein, meanwhile, an intraperitoneal injection of TCRalphabeta mAb (500 microg) was given. On day 2, CD80 mAb was administered intraperitoneally. Skin grafting was performed on day 6. Delayed type hypersensitivity (DTH), mixed lymphocyte reaction (MLR), IL-2 reverse assay of MLR, adoptive transfer assay and chimerism detection were performed at different time points and tolerance mechanisms were investigated. RESULTS: The mean survival time (MST) of BALB/c skin allografts in C57BL/6 recipients that were treated by anti-TCRalphabeta and anti-CD80 mAbs combined with donor BMCs infusion was 70 days. DTH and MLR assay indicated that the tolerant mice displayed significant hyporesponsiveness. The result of IL-2 reverse test showed that clone anergy was probably involved in the formation of tolerance in the tolerant C57BL/6 mice. In vivo and in vitro adoptive transfer assay, suppressive activity in the spleens of tolerant C57BL/6 mice was observed. Chimerism existed in both the thymus and spleen of the tolerant C57BL/6 mice. The chimerism level gradually declined with time. CONCLUSION: Treatment of anti-TCRalphabeta and anti-CD80 mAbs combined with donor BMCs infusion can successfully induce a long-term tolerance in BALB/c mice to C57BL/6 skin graft. Multiple mechanisms, including clone anergy, suppressor cells and chimerism are involved in the tolerance. FAU - Hao, Jie AU - Hao J AD - Department of Immunology, School of Basic Medical Sciences, Peking University, Beijing 100083, China. FAU - Liu, Jia-wang AU - Liu JW FAU - Gao, Xiang AU - Gao X FAU - Yuan, Guo-hong AU - Yuan GH FAU - Xie, Shu-sheng AU - Xie SS LA - chi PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Beijing Da Xue Xue Bao Yi Xue Ban JT - Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences JID - 101125284 RN - 0 (Antibodies, Monoclonal) RN - 0 (CD8 Antigens) RN - 0 (Receptors, Antigen, T-Cell, alpha-beta) SB - IM MH - Animals MH - Antibodies, Monoclonal/*administration & dosage/immunology MH - *Bone Marrow Transplantation MH - CD8 Antigens/*immunology MH - Clonal Anergy/immunology MH - Female MH - Immune Tolerance/drug effects/immunology MH - Lymphocyte Culture Test, Mixed MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Receptors, Antigen, T-Cell, alpha-beta/*immunology MH - Skin Transplantation/*immunology EDAT- 2006/08/08 09:00 MHDA- 2008/05/28 09:00 CRDT- 2006/08/08 09:00 PHST- 2006/08/08 09:00 [pubmed] PHST- 2008/05/28 09:00 [medline] PHST- 2006/08/08 09:00 [entrez] PST - ppublish SO - Beijing Da Xue Xue Bao Yi Xue Ban. 2006 Aug 18;38(4):365-9.